Development of a Novel Dendritic Cell-Based Immunotherapy Targeting Cancer Stem Cells.
AuthID
P-00R-4A3
P-00R-4A3
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service